Prostate Cancer

Get everyday updates on prostate cancer publication.
A student initiative to help prostate cancer research community on Twitter.

[Prostate Cancer @CaP_pubs]

A student-initiated account to help #ProstateCancer research community on Twitter.

Follow this account, and you will be notified on all publication (small or big) related to #prostate #cancer, soon after they appear on #PubMed.

Please Like & Retweet to spread the word.

[Balaji @Bajji]

Excited to share our new study in 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝!
We focus on PROX1 as a key driver of neuroendocrine #ProstateCancer and highlight its potential as a therapeutic target.
Huge thanks to @mishabeltran for her mentorship!

https://t.co/0rfnsvFSUX

@PCF_Science @CDMRP

[Prostate Cancer @CaP_pubs]

Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancer. 𝘾𝙖𝙣𝙘𝙚𝙧 𝘿𝙞𝙨𝙘𝙤𝙫.

@VRodriguezBravo @DomingoDomenech

#ProstateCancer
https://t.co/QTfe9ZOSKt

[Prostate Cancer @CaP_pubs]

KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy. 𝘾𝙖𝙣𝙘𝙚𝙧 𝘾𝙚𝙡𝙡.

#ProstateCancer

https://t.co/j4rzpAp7v2

[Prostate Cancer @CaP_pubs]

Spatially resolved transcriptomic analysis of the adult human prostate. 𝙉𝙖𝙩 𝙂𝙚𝙣𝙚𝙩.

#ProstateCancer

https://t.co/WRx1sMErvI

[Prostate Cancer @CaP_pubs]

Engineering sonogenetic EchoBack-CAR T cells. 𝘾𝙚𝙡𝙡.

#ProstateCancer
https://t.co/xJzwdcxILK

[Prostate Cancer @CaP_pubs]

Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality. 𝘾𝙡𝙞𝙣 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨.

#ProstateCancer
https://t.co/4MKale8mYz

[Prostate Cancer @CaP_pubs]

Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer. 𝘾𝙡𝙞𝙣 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨.

#ProstateCancer
https://t.co/qwjKjAtjxZ

[Prostate Cancer @CaP_pubs]

Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells. 𝙈𝙤𝙡 𝘾𝙖𝙣𝙘𝙚𝙧 𝙏𝙝𝙚𝙧.

#ProstateCancer
https://t.co/Hq8mgmNcSj

[Prostate Cancer @CaP_pubs]

ETV5 reduces androgen receptor expression and induces neural stem-like properties during neuroendocrine #ProstateCancer development. 𝙋𝙧𝙤𝙘 𝙉𝙖𝙩𝙡 𝘼𝙘𝙖𝙙 𝙎𝙘𝙞.

https://t.co/AiaeeOv8CA

[Prostate Cancer @CaP_pubs]

Tumour-wide RNA splicing aberrations generate actionable public neoantigens. 𝙉𝙖𝙩𝙪𝙧𝙚.

#ProstateCancer
https://t.co/AqbsMjxJfb

[Prostate Cancer @CaP_pubs]

Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer. ��𝙚𝙡𝙡 𝘿𝙚𝙖𝙩𝙝 𝘿𝙞𝙨.

#ProstateCancer
https://t.co/dWymbnzW8Y

[Prostate Cancer @CaP_pubs]

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. 𝙉𝙖𝙩 𝘾𝙤𝙢𝙢𝙪𝙣.

#ProstateCancer
https://t.co/EsY9rIeEad

[Prostate Cancer @CaP_pubs]

CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer. 𝘾𝙚𝙡𝙡 𝙍𝙚𝙥.

#ProstateCancer
@TakedaDavid

https://t.co/JUD2TNR8qN

[Prostate Cancer @CaP_pubs]

Targeting ADAR1 with a small molecule for the treatment of prostate cancer. 𝙉𝙖𝙩 𝘾𝙖𝙣𝙘𝙚𝙧.

#ProstateCancer
https://t.co/NhmHN27nL9

[Prostate Cancer @CaP_pubs]

Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups. 𝙉𝙖𝙩 𝙂𝙚𝙣𝙚𝙩.

#ProstateCancer
https://t.co/sEc2j8wyz8

[Prostate Cancer @CaP_pubs]

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth. 𝘾𝙡𝙞𝙣 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨.

@AdamSharpMedOnc

#ProstateCancer

https://t.co/VFDLOouDSA

[Prostate Cancer @CaP_pubs]

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. 𝙉𝙖𝙩 𝘾𝙤𝙢𝙢𝙪𝙣.

#ProstateCancer
https://t.co/8i7GZWIJDf

[Elizabeth McKenna @ElizSMcKenna]

Now online in @CD_AACR: Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in #ProstateCancer -by Lisa Chesner, @felixfengmd, @Moran_Lab, and colleagues https://t.co/PR5aMT8nzQ @UCSFCancer @OHSUKnight

[Prostate Cancer @CaP_pubs]

Plasma cell-free DNA chromatin immunoprecipitation profiling depicts phenotypic and clinical heterogeneity in advanced prostate cancer. 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨.

https://t.co/OuwDx2z9wT

[Prostate Cancer @CaP_pubs]

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. 𝙉𝙖𝙩 𝘾𝙤𝙢𝙢𝙪𝙣.

#ProstateCancer
https://t.co/H8JKIeR0sb